Archive: portfolio recommendation
Behind the Pick: Phoenix PharmaLabs
By Early Investing on March 25, 2019
First Stage Investor Co-Founder Andy Gordon takes a deeper dive into why he likes Phoenix Pharma Labs so much and the "X" factor that put them over the top.
HyperSciences Works With NASA, 20/20 GeneSystems Expands Its Reach
By Andy Gordon on February 11, 2019
This week, we’re checking in with two of our portfolio companies. HyperSciences is planning a big field test of its technology, while 20/20 GeneSystems is expanding its reach.